+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asthma Drugs Market Research Reports

From
From
From
From
From
From
From
Asthma - Competitive landscape, 2023 - Product Thumbnail Image

Asthma - Competitive landscape, 2023

  • Report
  • April 2023
  • 240 Pages
  • Global
From
NUCALA Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

NUCALA Drug Insight and Market Forecast - 2032

  • Report
  • August 2022
  • 30 Pages
  • Global
From
Sarcopenia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Sarcopenia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Severe Asthma - Epidemiology Forecast - 2032 - Product Thumbnail Image

Severe Asthma - Epidemiology Forecast - 2032

  • Report
  • June 2022
  • 95 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers. Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more